All News
Polymyalgia rheumatica: more than just steroids at ACR22
After decades of having little else proven apart from glucocorticosteroids with which to treat polymyalgia rheumatica (PMR), evidence for steroid-sparing options has grown in recent years, and this crescendo is set to continue at ACR Convergence 2022 in Philadelphia, PA.
Read Article
Industry Abstract Previews of ACR 2022
The pharmaceutical companies have will showcase their featured clinical trials and abstracts at ACR 2022. These are their best studies for you to review and evaluate as part of your to-do list.
Read Article
Prelude to a Meeting (ACR22) (11.11.2022)
Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com and looks forward to highlight sessions in the next few days at ACR Convergence 2022.
Read Article
What's the clinical use of imaging in #osteoarthritis?
👉Useful in atypical presentations, NOT required for dx
👉Always consider the view (particularly knees)
👉No evidence in predicting response to non-surgical tx
#ACR22 @RheumNow #acrreview https://t.co/nlRI1dbbud
sheila RHEUMarampa ( View Tweet)
#Exercise does NOT increase the risk for knee replacement but can provide a protective effect - Dr Scanzelloe on #OA @rheumnow #acr22 #acrreview https://t.co/a8Q1FLUvcw
TheDaoIndex KDAO2011 ( View Tweet)
Exciting time to be doing research in GCA! Over half a dozen ongoing RCTs
Challenging to recruit enough patients given (1) competing trials (2) reticence to join a trial when tocilizumab (standard of care) is available
#ACR22 #Vasculitis22 @RheumNow https://t.co/mJm69gH4N9
Mike Putman EBRheum ( View Tweet)
❗Encouraging weight loss in #osteoarthritis is really challenging! @rheumarhyme
But this slide👇 is reassuring and we can use it to motivate our patients.
#ACR22 @rheumnow #acrreview https://t.co/hUa56UfJPA
sheila RHEUMarampa ( View Tweet)
Short-term intra-articular steroids are effective (unclear- long term benefits) - no increase risk for knee replacement with repeat steroid injx #osteoarthritis @rheumnow #acr22 #acrreview https://t.co/MJHXWePF70
TheDaoIndex KDAO2011 ( View Tweet)
Nice summary slide of the recently published 2022 Classification Criteria for GCA and TAK!
Avalable free!
TAK: https://t.co/0aMVPvKgyE
GCA: https://t.co/s1aiFpq3r2
#ACR22 #Vasculitis22 @RheumNow https://t.co/x9ufxi7aco
Links:
Mike Putman EBRheum ( View Tweet)
Medicare will cover #DXA testing for these diagnoses @RheumNow #acr22 #acrreview https://t.co/keZg0fxyz9
TheDaoIndex KDAO2011 ( View Tweet)
Did You Know? FDA relaxed warnings on #sarcoma with #Forteo- can use more than 2 years @RheumNow #acr22 #acrreview #osteoporosis https://t.co/Xzr6TZIlWN
TheDaoIndex KDAO2011 ( View Tweet)
Drug holidays for #osteoporosis RX but be note fracture risk may increase with these holidays- consider an anabolic agent during these times - Dr Tanner #acr22 @RheumNow #acrreview https://t.co/6XbpYD5D1X
TheDaoIndex KDAO2011 ( View Tweet)
Dr Tanner presents the features of AFF👇
It is rare, subtrochanteric in location and often appears w/n 5-10 yrs of BP use.
#ACR22 @RheumNow #acrreview #osteoporosis https://t.co/KbMJ4dXfpj
sheila RHEUMarampa ( View Tweet)
P1NP is a useful bone turnover marker that Dr. Tanner checks to monitor #osteoporosis therapy (if insurance covers it) - it is not affected by diurnal variation, food, renal function. #ACR22 @rheumnow #ACRReview
TheDaoIndex KDAO2011 ( View Tweet)
Here's a nice slide comparing Sjogren's disease and Sarcoidosis:
#ACR22 @RheumNow #acrreview #MedTwitter https://t.co/MQQx3GBl5f
sheila RHEUMarampa ( View Tweet)
Abbvie launching another upadacitinib phase 3 trial w/essentially zero preliinary data
I personally love this strategy; I think Phase 2's are an expensive waste of time
Better to go big and answer the question?
COI: I participate in SELECT-GCA
#ACR22 @RheumNow #Vasculitis22 https://t.co/fSs3xt8baA
Mike Putman EBRheum ( View Tweet)
Withdrawing IL17i will more likely cause a relapse, but pts will respond when reintroduced -Dr Scher #PsA @rheumnow #acr22 #acrreview https://t.co/FvWVuQGJda
TheDaoIndex KDAO2011 ( View Tweet)
Dr. Sheila Reyes is back and covering #ACR22 as a RheumNow reporter. Follow @RHEUMarampa from real-time conference coverage! https://t.co/MeA2RggI9S
Dr. John Cush RheumNow ( View Tweet)
Sialadenosis is a mimic of #sjogren - it related to fatty infiltration/metabolic syndrome. Correct underlying issue and pts will improve - Dr S McCoy @rheumnow #acrreview #acr22 https://t.co/bZPj1LmERs
TheDaoIndex KDAO2011 ( View Tweet)
Wonderful slide by Dr. Sarah McCoy on #Sjogrens #ACR22 @RheumNow
Broad differential for these patients when they present in clinic:
📍Ask about:
🚬 habits
💊 meds
🍬 🩻history: #diabetes, past radiation exposure
🦠 infection (#HIV, #HCV)
🩸 #vitamin deficiency https://t.co/6Qo23lWBs4
Catherine Sims, MD DrCassySims ( View Tweet)
